Time for integrating clinical, lifestyle and molecular data to predict drug responses — Authors' reply
Main Authors: | Anton Pottegård, Søren Friis, René dePont Christensen, Laurel A. Habel, Joshua J. Gagne, Jesper Hallas |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-05-01
|
Series: | EBioMedicine |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352396416301050 |
Similar Items
-
Identification of Associations Between Prescribed Medications and Cancer: A Nationwide Screening Study
by: Anton Pottegård, et al.
Published: (2016-05-01) -
The Validity of Danish Prescription Data to Measure Use of Aspirin and Other Non-Steroidal Anti-Inflammatory Drugs and Quantification of Bias Due to Non-Prescription Drug Use
by: Gaster N, et al.
Published: (2021-07-01) -
A new likelihood model for analyses of pharmacoepidemiologic case–control studies which avoids decision rules for determining latent exposure status
by: Henrik Støvring, et al.
Published: (2021-07-01) -
Generic switching and non-persistence among medicine users: a combined population-based questionnaire and register study.
by: Jette Rathe, et al.
Published: (2015-01-01) -
Multifaceted Intervention Including Motivational Interviewing to Support Medication Adherence after Stroke/Transient Ischemic Attack: A Randomized Trial
by: Ulla Hedegaard, et al.
Published: (2014-12-01)